{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:31:57Z","timestamp":1790875917423,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"DOI":"10.1186\/s13027-024-00627-x","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T12:04:21Z","timestamp":1737547461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An exploratory study on the differential diagnostic indicators between adult systemic EBV-positive T-cell lymphoproliferative disorders and angioimmunoblastic T-cell lymphoma with multiple EBV infections"],"prefix":"10.1186","volume":"20","author":[{"given":"Xiaodan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoge","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"issue":"7335","key":"627_CR1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma. Lancet. 1964;1(7335):702\u20133.","journal-title":"Lancet"},{"issue":"7","key":"627_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000;343(7):481\u201392.","journal-title":"N Engl J Med"},{"issue":"9","key":"627_CR3","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","volume":"20","author":"JI Cohen","year":"2009","unstructured":"Cohen JI, Kimura H, Nakamura S, et al. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8\u20139 September 2008. Ann Oncol. 2009;20(9):1472\u201382.","journal-title":"Ann Oncol"},{"key":"627_CR4","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","volume":"117","author":"JI Cohen","year":"2011","unstructured":"Cohen JI, Jaffe ES, Dale JK, et al. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011;117:5835\u201349.","journal-title":"Blood"},{"key":"627_CR5","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1182\/blood.V98.10.3173","volume":"98","author":"K Kawa","year":"2001","unstructured":"Kawa K, Okamura T, Yagi K, Takeuchi M, Nakayama M, Inoue M. Mosquito allergy and Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disease. Blood. 2001;98:3173\u201374.","journal-title":"Blood"},{"key":"627_CR6","unstructured":"Quintanilla-Martinez L, Ko YH, Kimura H, Jaffffe ES et al. EBV\u2013positive T-cell and NK-cell lymphoproliferative diseases of childhood. In: Swerdlow SH, Campo E, Harris NL, Jaffffe ES, Pileri SA, Stein H, editors. WHO Classifification of Tumours of Haematopoietic and Lymphoid Tissues. revised 4th ed. Lyon: WHO IARC Press; 2017. pp. 355\u2009\u2013\u200962."},{"issue":"7","key":"627_CR7","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization classifcation of haematolymphoid tumours: lymphoid neo-plasms. Leukemia. 2022;36(7):1720\u201348.","journal-title":"Leukemia"},{"issue":"11","key":"627_CR8","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jafe ES, Cook JR, et al. The international consensus classifcation of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood. 2022;140(11):1229\u201353.","journal-title":"Blood"},{"issue":"5","key":"627_CR9","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s12185-011-0831-x","volume":"93","author":"A Arai","year":"2011","unstructured":"Arai A, Imadome KI, Watanabe Y, et al. Clinical features of adult-onset chronic active Epstein-Barr virus infection: a retrospective analysis. Int J Hematol. 2011;93(5):602\u20139.","journal-title":"Int J Hematol"},{"issue":"3","key":"627_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/jclinpath-2011-200523","volume":"65","author":"Y Isobe","year":"2012","unstructured":"Isobe Y, Aritaka N, et al. T\/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T\/NK-cell lymphoma. J Clin Pathol. 2012;65(3):278\u201382.","journal-title":"J Clin Pathol"},{"issue":"6","key":"627_CR11","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3324\/haematol.2017.174177","volume":"103","author":"K Kawamoto","year":"2018","unstructured":"Kawamoto K, Miyoshi H, Suzuki T, et al. A distinct subtype of Epstein-Barr virus-positive T\/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features. Haematologica. 2018;103(6):1018\u201328.","journal-title":"Haematologica"},{"issue":"3","key":"627_CR12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41564-018-0334-0","volume":"4","author":"Y Okuno","year":"2019","unstructured":"Okuno Y, Murata T, Sato Y, et al. Defective Epstein-Barr virus in chronic active infection and haematological malignancy. Nat Microbiol. 2019;4(3):404\u201313.","journal-title":"Nat Microbiol"},{"key":"627_CR13","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ng.3358","volume":"47","author":"L Jiang","year":"2015","unstructured":"Jiang L, Gu Z-H, Yan Z-X, et al. Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma. Nat Genet. 2015;47:1061\u20136.","journal-title":"Nat Genet"},{"issue":"9","key":"627_CR14","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1097\/PAS.0000000000001315","volume":"43","author":"M Basma","year":"2019","unstructured":"Basma M, Basha,Sandra C, Bryant,Karen L, Rech, et al. Application of a 5 Marker Panel to the routine diagnosis of peripheral T-Cell lymphoma with T-Follicular helper phenotype. Am J Surg Pathol. 2019;43(9):1282\u201390.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"627_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/ng.2872","volume":"46","author":"M Sakata-Yanagimoto","year":"2014","unstructured":"Sakata-Yanagimoto M, Enami T, Yoshida K, et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46(2):171\u20135.","journal-title":"Nat Genet"},{"issue":"1","key":"627_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40164-021-00224-3","volume":"10","author":"SE Yoon","year":"2021","unstructured":"Yoon SE, Cho J, Kim YJ, et al. Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas. Exp Hematol Oncol. 2021;10(1):33.","journal-title":"Exp Hematol Oncol"},{"issue":"11","key":"627_CR17","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","volume":"128","author":"D Vallois","year":"2016","unstructured":"Vallois D, Dobay MP, Morin RD, et al. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas. Blood. 2016;128(11):1490\u2013502.","journal-title":"Blood"},{"issue":"9","key":"627_CR18","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","volume":"123","author":"O Odejide","year":"2014","unstructured":"Odejide O, Weigert O, Lane AA, et al. A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood. 2014;123(9):1293\u20136.","journal-title":"Blood"},{"key":"627_CR19","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","volume":"126","author":"C Wang","year":"2015","unstructured":"Wang C, McKeithan TW, Gong Q, Zhang W, Bouska A, Rosenwald A, et al. IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma. Blood. 2015;126:1741\u201352.","journal-title":"Blood"},{"issue":"1","key":"627_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ajh.20398","volume":"80","author":"M Okano","year":"2005","unstructured":"Okano M, Kawa K, Kimura H, et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol. 2005;80(1):64\u20139.","journal-title":"Am J Hematol"},{"issue":"3","key":"627_CR21","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","volume":"119","author":"H Kimura","year":"2012","unstructured":"Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, et al. EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119(3):673\u201386.","journal-title":"Blood"},{"issue":"5","key":"627_CR22","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s12185-023-03660-5","volume":"118","author":"Y Jun-ichi Kawada","year":"2023","unstructured":"Jun-ichi Kawada Y, Ito K, Ohshima, et al. Updated guidelines for chronic active Epstein\u2013Barr virus disease. Int J Hematol. 2023;118(5):568\u201376.","journal-title":"Int J Hematol"},{"key":"627_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/ajcp\/aqv010","volume":"145","author":"Y Huang","year":"2016","unstructured":"Huang Y, Xie J, Ding Y, Zhou X. Extranodal natural killer\/T-cell lymphoma in children and adolescents: a report of 17 cases in China. Am J Clin Pathol. 2016;145:46\u201354.","journal-title":"Am J Clin Pathol"},{"key":"627_CR24","doi-asserted-by":"crossref","unstructured":"Van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia 17:2257\u2013317.","DOI":"10.1038\/sj.leu.2403202"},{"issue":"1","key":"627_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.semdp.2019.12.004","volume":"37","author":"IA Montes-Mojarro","year":"2020","unstructured":"Montes-Mojarro IA, Kim WY, Fend F, Quintanilla-Martinez L. EpsteinBarr virus positive T and NK-cell lymphoproliferations: morphological features and differential diagnosis. Semin Diagn Pathol. 2020;37(1):32\u201346.","journal-title":"Semin Diagn Pathol"},{"issue":"3","key":"627_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S1040-8428(02)00118-X","volume":"44","author":"M Okano","year":"2002","unstructured":"Okano M. Overview and problematic standpoints of severe chronic active Epstein-Barr virus infection syndrome. Crit Rev Oncol Hematol. 2002;44(3):273\u201382.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"13","key":"627_CR27","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1182\/bloodadvances.2020001451","volume":"4","author":"I Yonese","year":"2020","unstructured":"Yonese I, Sakashita C, Imadome KI, Kobayashi T, Yamamoto M, Sawada A, et al. Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classifcation. Blood Adv. 2020;4(13):2918\u201326.","journal-title":"Blood Adv"},{"issue":"9","key":"627_CR28","doi-asserted-by":"publisher","first-page":"e9854","DOI":"10.1097\/MD.0000000000009854","volume":"97","author":"H Ling Luo","year":"2018","unstructured":"Ling Luo H, Wang H. The clinical characteristics and the features of immunophenotype of peripheral lymphocytes of adult onset chronic active Epstein-Barr virus disease at a Tertiary Care Hospital in Beijing. Med (Baltim). 2018;97(9):e9854.","journal-title":"Med (Baltim)"},{"issue":"2","key":"627_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/ped.12314","volume":"56","author":"S Fujiwara","year":"2014","unstructured":"Fujiwara S, Kimura H, Imadome K, et al. Current research on chronic active Epstein-Barr virus infection in Japan. Pediatr Int. 2014;56(2):159\u201366.","journal-title":"Pediatr Int"},{"key":"627_CR30","doi-asserted-by":"publisher","first-page":"1177590","DOI":"10.3389\/fonc.2023.1177590","volume":"13","author":"LAPC Lage","year":"2023","unstructured":"Lage LAPC, Culler HF, et al. Angioimmunoblastic T-cell lymphoma and correlated neoplasms with T-cell follicular helper phenotype: from molecular mechanisms to therapeutic advances. Front Oncol. 2023;13:1177590.","journal-title":"Front Oncol"},{"key":"627_CR31","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","volume":"102","author":"MP Dobay","year":"2017","unstructured":"Dobay MP, Lemonnier F, Missiaglia E, Bastard C, Vallois D, et al. Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin. Haematologica. 2017;102:e148\u201351.","journal-title":"Haematologica"},{"issue":"4","key":"627_CR32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1086\/427239","volume":"191","author":"H Kimura","year":"2005","unstructured":"Kimura H, Hoshino Y, Hara S, Sugaya N, Kawada J, Shibata Y, et al. Diferences between T cell-type and natural killer celltype chronic active Epstein\u2013Barr virus infection. J Infect Dis. 2005;191(4):531\u20139.","journal-title":"J Infect Dis"},{"issue":"9","key":"627_CR33","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1097\/PAS.0000000000001315","volume":"43","author":"M Basma","year":"2019","unstructured":"Basma M, Basha SC, Bryant, Karen L, Rech, et al. Application of a 5 Marker Panel to the routine diagnosis of peripheral T-Cell lymphoma with T-Follicular helper phenotype. Am J Surg Pathol. Sep; 2019;43(9):1282\u201390.","journal-title":"Am J Surg Pathol"},{"key":"627_CR34","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1182\/blood-2011-08-374371","volume":"119","author":"T Tokunaga","year":"2012","unstructured":"Tokunaga T, Shimada K, Yamamoto K, Chihara D, Ichihashi T, et al. Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan. Blood. 2012;119:2837\u201343.","journal-title":"Blood"},{"key":"627_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/ajcp\/aqaa249","volume":"156","author":"MBBS Ibrahim Abukhiran","year":"2021","unstructured":"Ibrahim Abukhiran MBBS, et al. Markers of Follicular Helper T Cells are occasionally expressed in T-Cell or histiocyte-rich large B-Cell lymphoma, Classic Hodgkin Lymphoma, and Atypical Paracortical Hyperplasia. Am J Clin Pathol. Sep; 2021;156:409\u201326.","journal-title":"Am J Clin Pathol"},{"key":"627_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.clml.2016.10.001","volume":"17","author":"ED Hsi","year":"2017","unstructured":"Hsi ED, Horwitz SM, Carson KR, Pinter-Brown LC, Rosen ST, et al. Analysis of peripheral T-cell Lymphoma Diagnostic Workup in the United States. Clin Lymphoma Myeloma Leuk. 2017;17:193\u2013200.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"627_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/his.14919","volume":"83","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Wang Z, et al. A nodal EBV-positive T cell lymphoma with a T follicular helper cell phenotype. Histopathology. 2023;83:137\u201342.","journal-title":"Histopathology"},{"key":"627_CR38","doi-asserted-by":"publisher","first-page":"346357","DOI":"10.1002\/path.5376","volume":"250","author":"W-Q Yao","year":"2020","unstructured":"Yao W-Q, Wu F, Zhang W, et al. Angioimmunoblastic T-cell lymphoma contains multiple clonalt-cell populations derived from a common TET2 mutantprogenitor cell. J Pathol. 2020;250:346357.","journal-title":"J Pathol"},{"issue":"3","key":"627_CR39","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3960\/jslrt.17019","volume":"57","author":"M Fujisawa","year":"2017","unstructured":"Fujisawa M, Chiba S, Sakata-Yanagimoto M, et al. Recent progress in the understanding of angioimmunoblastic T-cell lymphoma. J Clin Exp Hematop. 2017;57(3):109\u201319.","journal-title":"J Clin Exp Hematop"},{"key":"627_CR40","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","volume":"126","author":"C Wang","year":"2015","unstructured":"Wang C, McKeithan TW, Gong Q, et al. IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma. Blood. 2015;126:1741\u201352.","journal-title":"Blood"},{"key":"627_CR41","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, et al. The International Consensus classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee. Blood. 2022;140:1229\u201353.","journal-title":"Blood"},{"key":"627_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/ng.2872","volume":"46","author":"M Sakata-Yanagimoto","year":"2014","unstructured":"Sakata-Yanagimoto M, Enami T, Yoshida K, Shiraishi Y, Ishii R, et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46:171\u20135.","journal-title":"Nat Genet"},{"key":"627_CR43","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","volume":"119","author":"RA Cairns","year":"2012","unstructured":"Cairns RA, Iqbal J, Lemonnier F, Kucuk C, de Leval L, et al. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood. 2012;119:1901\u20133.","journal-title":"Blood"},{"key":"627_CR44","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ng.2873","volume":"46","author":"T Palomero","year":"2014","unstructured":"Palomero T, Couronne L, Khiabanian H, Kim MY, AmbesiImpiombato A, et al. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet. 2014;46:166\u201370.","journal-title":"Nat Genet"},{"key":"627_CR45","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/ng.2916","volume":"46","author":"HY Yoo","year":"2014","unstructured":"Yoo HY, Sung MK, Lee SH, et al. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46:371\u20135.","journal-title":"Nat Genet"},{"key":"627_CR46","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/MOH.0000000000000261","volume":"23","author":"JR Cort\u00e9s","year":"2016","unstructured":"Cort\u00e9s JR, Palomero T. The curious origins of angioimmunoblastic T-cell lymphoma. Curr Opin Hematol. 2016;23:434\u201343.","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"627_CR47","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","volume":"31","author":"M Federico","year":"2013","unstructured":"Federico M, Rudiger T, Bellei M, Nathwani BN, Luminari S, Coiffier B, et al. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol off J Am Soc Clin Oncol. 2013;31(2):240\u20136.","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"issue":"9","key":"627_CR48","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","volume":"111","author":"N Mourad","year":"2008","unstructured":"Mourad N, Mounier N, Bri\u00e8re J, Raffoux E, Delmer A, Feller A, et al. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the groupe d\u2019etude des lymphomes de l\u2019adulte (Gela) trials. Blood. 2008;111(9):4463\u201370.","journal-title":"Blood"},{"issue":"3","key":"627_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1182\/blood.2020010387","volume":"138","author":"RH Advani","year":"2021","unstructured":"Advani RH, Skrypets T, Civallero M, Spinner MA, Manni M, Kim WS, et al. Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell project. Blood. 2021;138(3):213\u201320.","journal-title":"Blood"},{"issue":"5","key":"627_CR50","doi-asserted-by":"publisher","first-page":"536","DOI":"10.21147\/j.issn.1000-9604.2023.05.10","volume":"35","author":"X Yunfei Shi","year":"2023","unstructured":"Yunfei Shi X, Li W, Liu J, Zhu, et al. Genetic abnormalities assist in pathological diagnosis and EBVpositive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients. Chin J Cancer Res. 2023;35(5):536\u201349.","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"627_CR51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/bmt.2010.122","volume":"46","author":"K Kawa","year":"2011","unstructured":"Kawa K, Sawada A, Sato M, Okamura T, Sakata N, Kondo O, et al. Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection. Bone Marrow Transpl. 2011;46(1):77\u201383.","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"627_CR52","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12185-017-2192-6","volume":"105","author":"A Sawada","year":"2017","unstructured":"Sawada A, Inoue M, Kawa K. How we treat chronic active Epstein\u2013Barr virus infection. Int J Hematol. 2017;105(4):406\u201318.","journal-title":"Int J Hematol"},{"issue":"3","key":"627_CR53","doi-asserted-by":"publisher","first-page":"e0174136","DOI":"10.1371\/journal.pone.0174136","volume":"12","author":"H Takada","year":"2017","unstructured":"Takada H, Imadome KI, Shibayama H, et al. EBV induces persistent NF-\u03baB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells. PLoS ONE. 2017;12(3):e0174136.","journal-title":"PLoS ONE"},{"issue":"21","key":"627_CR54","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1158\/1078-0432.CCR-13-3172","volume":"20","author":"J Kawada","year":"2014","unstructured":"Kawada J, Ito Y, Iwata S, et al. mTOR inhibitors induce cell-cycle arrest and inhibit tumor growth in Epstein\u2013Barr virus-associated T and natural killer cell lymphoma cells. Clin Cancer Res J Am Assoc Cancer Res. 2014;20(21):5412\u201322.","journal-title":"Clin Cancer Res J Am Assoc Cancer Res"},{"issue":"47","key":"627_CR55","doi-asserted-by":"publisher","first-page":"76793","DOI":"10.18632\/oncotarget.12529","volume":"7","author":"S Ando","year":"2016","unstructured":"Ando S, Kawada JI, Watanabe T, et al. Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein\u2013Barr virus-associated T and natural killer cell lymphoma cells. Oncotarget. 2016;7(47):76793\u2013805.","journal-title":"Oncotarget"},{"issue":"57","key":"627_CR56","doi-asserted-by":"publisher","first-page":"31077","DOI":"10.18632\/oncotarget.25780","volume":"9","author":"E Onozawa","year":"2018","unstructured":"Onozawa E, Shibayama H, Takada H, et al. STAT3 is constitutively activated in chronicactive Epstein\u2013Barr virus infection and can be a therapeutic target. Oncotarget. 2018;9(57):31077\u201389.","journal-title":"Oncotarget"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-024-00627-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-024-00627-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-024-00627-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T12:14:48Z","timestamp":1737548088000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-024-00627-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["627"],"URL":"https:\/\/doi.org\/10.1186\/s13027-024-00627-x","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"assertion":[{"value":"4 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were conducted in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and the Helsinki Declaration of 1964 and its later versions. Informed consent was obtained from all the participants. Ethical approval was obtained from the Ethical Review Board of the Beijing Friendship Hospital, Capital Medical University (No. 2024-P2-354-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}